Want to join the conversation?
$OREX 2Q15 Call: OREX has agreed to pay for the new cardiovascular outcomes trial up to estimated $210MM total cost of study. If cost exceeds this estimate, the parties will share cost generally equally. Takeda will pay the remaining cost of closing MRI study. Takeda will also pay 75% of cost of all other development activities for Contrave in US.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?